Notice of Correction to PAR-22-131, Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional)
National Institutes of Health
Type
Research/project funding
Posted on:
Notice NOT-CA-24-004 from the NIH Guide for Grants and Contracts